Max Planck Institute of Biochemistry, Lead Discovery Center and Qurient Close License Deal on a New Compound Against Metastatic and Drug-Resistant Cancers
3/12/2013 10:32:55 AM
More...
|
Lead Discovery Center Participates in New Pan-European Drug Discovery Platform
2/12/2013 11:15:14 AM
More...
|
Lead Discovery Center Forms Drug Discovery Alliance With AstraZeneca PLC (AZN)
1/25/2013 9:40:41 AM
More...
|
Anti-Cancer Project Originating From Lead Discovery Center Reaches Next Milestone
9/20/2012 10:43:07 AM
More...
|
Lead Discovery Center and Bayer Schering Pharma Enter Into License Agreement Covering a Novel Pharmaceutical Lead Structure
4/19/2011 9:58:55 AM
More...
|
Lead Discovery Center and Merck KGaA (MKGAF.PK) Enter Collaboration for the Discovery of Anti-Cancer Compounds
1/20/2011 9:49:28 AM
More...
|
InterMed Discovery Announces Collaboration Agreement With the Lead Discovery Center
4/2/2009 12:20:08 PM
More...
|
Max Planck Society's Technology Transfer Agency Max Planck Innovation GmbH Announces Lead Discovery Center Start of Operations
6/18/2008 11:55:28 AM
More...
|